Skip to content
value.today
Hyperfine, Inc. logo

Hyperfine, Inc.

HYPR
$78 Mmarket cap on Oct 23, 2026-0.6% since Jan 2024
Compare
World rank
#19,682
Revenue
$14 M
For year ending December-2025
Net income
$-36 M
-262.3% margin
SEC filing
Employees
102
As of February 15, 2026
SEC filing

Hyperfine, Inc. in brief

Hyperfine, Inc. is a listed company in the Medical Devices industry, based in Guilford, Connecticut, USA. Its market value was $78 M on 23 October 2026, which makes it the 19,682nd largest listed company in the world and the 3,655th largest in the USA on this site. In the year to December 2025 it had sales of $14 M and a net loss of $36 M. It employs about 102 people and Maria Sainz is its chief executive. Its shares trade under the symbol HYPR (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Hyperfine, Inc.

We are an innovative health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence-powered portable ultra-low-field magnetic resonance brain imaging. Our Swoop® Portable MR Imaging® System produces high-quality images at a significantly lower magnetic field strength than conventional magnetic resonance imaging scanners. Our Swoop® system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated patient-friendly experience, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop® system is a portable, ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis. Healthcare professionals can use the Swoop® system to make effective clinical diagnoses and decisions in various care settings where conventional MRI devices are inaccessible and/or when they are not readily available. The portable design of our Swoop® system make it safely and readily accessible anywhere in a hospital, clinic, physician’s office, or patient care site and it does not require any special facilities accommodations. The easy to use, iPad-based interface makes its operation easy to learn and it does not require specialized personnel to operate safely. ULF MR does not expose patients to harmful ionizing radiation and compares favorably in this regard to X-ray computed tomography or positron emission tomography.

From the company's annual report filed with the US SEC: read the report

Hyperfine, Inc. timeline

4 events, 2020–2025
  1. 2020
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2021
  4. 🔔
    Initial public offering as HealthCor Catalio Acquisition Corp.
    Final prospectus filed with the SEC on 28 January 2021; shares registered for exchange trading on 26 January 2021. The blank-check company later merged with the business that carries the name today.
  5. ✎
    Renamed Hyperfine, Inc.
    Formerly HealthCor Catalio Acquisition Corp..
  6. 2025
  7. 💰
    Record revenue of $14 million
    FY2025, the highest of the 6 years on record.

Events of Hyperfine, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$57 M$114 M$171 M$228 M2023202420252026

World rank over time

▲ up 4,304 places since 2022
2022-12-25: #24038#24,03820222023-07-30: #17782#17,78220232024-01-05: #22680#22,68020242026-03-08: #9929#9,92920262026-08-01: #17524#17,52420262026-10-08: #19231#19,23120262026-10-23: #19734#19,7342026

Rank in USA: #4,621 (Dec 2022) · #3,556 (Jul 2023) · #3,855 (Jan 2024) · #1,929 (Mar 2026) · #3,446 (Aug 2026) · #3,588 (Oct 2026) · #3,659 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
4.1×
Price / book
1.9×
Free cash flow yield
-37.6%
Net margin (TTM)
-156.6%
Operating margin
-273.5%
Return on equity
-72.7%
Liabilities / assets
25.8%
Net debt
$-35M
Revenue growth
+5.2%
R&D / revenue
128.7%
Revenue per employee
$133 K
Profit per employee
$-349 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2020: revenue $0M, net income $-23M$0MFY20Fiscal year ending Dec 2021: revenue $2M, net income $-65M$2MFY21Fiscal year ending Dec 2022: revenue $7M, net income $-44M$7MFY22Fiscal year ending Dec 2023: revenue $11M, net income $-44M$11MFY23Fiscal year ending Dec 2024: revenue $13M, net income $-41M$13MFY24Fiscal year ending Dec 2025: revenue $14M, net income $-36M$14MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$14M+5.2%$-37M$-36M-262.3%
Dec 2024$13M+16.9%$-43M$-41M-315.9%
Dec 2023$11M+62.0%$-48M$-44M-401.1%
Dec 2022$7M+354.0%$-74M$-44M-649.6%
Dec 2021$2M+417.2%$-65M$-65M-4323.3%
Dec 2020$0M—$-23M$-23M-8079.3%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-28M$1M$-29M$-0.43—
Dec 2024$-39M$0M$-39M$-0.56—
Dec 2023$-42M$1M$-43M$-0.62—
Dec 2022$-72M$1M$-73M$-1.04—
Dec 2021$-47M$3M$-50M$-17.57—
Dec 2020$-22M$2M$-23M$-15.38—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$19M
Net income, trailing 12 months
$-30M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $2M, net income $-10M$2MDec ’24Three months to Mar 2025: revenue $2M, net income $-9M$2MMar ’25Three months to Jun 2025: revenue $3M, net income $-9M$3MJun ’25Three months to Sep 2025: revenue $3M, net income $-11M$3MSep ’25Three months to Dec 2025 (from the annual report): revenue $5M, net income $-6M$5MDec ’25Three months to Mar 2026: revenue $4M, net income $-9M$4MMar ’26Three months to Jun 2026: revenue $4M, net income $-9M$4MJun ’26Three months to Sep 2026: revenue $6M, net income $-6M$6MSep ’26

Latest quarter to Sep 2026: revenue $6M (+73.3% on a year earlier), net income $-6M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Hyperfine, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$14 M
Operating income
$-37 M
Net income
$-36 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$55 M
Total liabilities
$14 M
Total equity
$41 M

As of December-2025

Top 87 institutional investors in Hyperfine, Inc.#

As of Sep 30, 2026
87 institutions held 22.0 M shares (about 19.7% of the shares outstanding) on Sep 30, 2026. The ten largest hold 15.2%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Hyperfine, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.4,656,638-16,449 (-0.35%)4.17%$4 MNov 13, 2026
2Vanguard Capital Management LLC3,380,0870 (0.00%)3.03%$3 MNov 13, 2026
3Geode Capital Management, LLC1,947,462-13,349 (-0.68%)1.74%$2 MNov 6, 2026
4Fosun International Ltd1,742,0200 (0.00%)1.56%$1 MNov 10, 2026
5Catalio Capital Management, LP1,303,155-16,886 (-1.28%)1.17%$1 MNov 16, 2026
6State Street Corp1,033,366+16,396 (+1.61%)0.93%$1 MNov 12, 2026
7Alphabet Inc.898,7200 (0.00%)0.80%$1 MNov 6, 2026
8Renaissance Technologies LLC715,607-230,229 (-24.34%)0.64%$1 MNov 12, 2026
9Northern Trust Corp637,102+4,048 (+0.64%)0.57%$1 MNov 16, 2026
10Vanguard Fiduciary Trust Co630,622+63,513 (+11.20%)0.56%$1 MNov 13, 2026
11Vanguard Portfolio Management LLC547,502+302 (+0.06%)0.49%$0 MNov 13, 2026
12Russell Investments Group, Ltd.487,994+481,734 (+7695.43%)0.44%$0 MNov 6, 2026
13Squarepoint Ops LLC379,152+355,777 (+1522.04%)0.34%$0 MNov 9, 2026
14Citadel Advisors LLC347,058New0.31%$0 MNov 16, 2026
15Isthmus Partners, LLC313,3500 (0.00%)0.28%$0 MOct 21, 2026
16Bank of New York Mellon Corp310,4050 (0.00%)0.28%$0 MNov 5, 2026
17Charles Schwab Investment Management Inc190,2350 (0.00%)0.17%$0 MNov 16, 2026
18Nuveen, LLC175,441+72,610 (+70.61%)0.16%$0 MNov 10, 2026
19XTX Topco Ltd164,460+148,067 (+903.23%)0.15%$0 MNov 16, 2026
20Two Sigma Investments, LP145,150-180,849 (-55.48%)0.13%$0 MNov 16, 2026
21Empirical Financial Services, LLC d.b.a. Empirical Wealth Management127,725New0.11%$0 MOct 27, 2026
22Bridgeway Capital Management, LLC126,814-1,586 (-1.24%)0.11%$0 MNov 16, 2026
23Empowered Funds, LLC96,214New0.09%$0 MNov 13, 2026
24Goldman Sachs Group Inc90,917+56,689 (+165.62%)0.08%$0 MNov 16, 2026
25Cerity Partners LLC86,074+1,074 (+1.26%)0.08%$0 MNov 13, 2026
Show all 87: investors 26 to 87
Institutional investors 26 to 87 in Hyperfine, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Bank Of America Corp /de/76,090+31,246 (+69.68%)0.07%$0 MNov 16, 2026
27Tortoise Investment Management, LLC73,500+1,500 (+2.08%)0.07%$0 MNov 6, 2026
28Deutsche Bank AG\68,637-9,583 (-12.25%)0.06%$0 MNov 6, 2026
29Rhumbline Advisers65,583+11,770 (+21.87%)0.06%$0 MNov 10, 2026
30Price T Rowe Associates Inc /MD/64,1610 (0.00%)0.06%$0 MNov 16, 2026
31Kathmere Capital Management, LLC51,8130 (0.00%)0.05%$0 MOct 20, 2026
32Invesco Ltd.51,557+9,022 (+21.21%)0.05%$0 MNov 12, 2026
33PFS Partners, LLC50,000+30,000 (+150.00%)0.04%$0 MOct 21, 2026
34Signaturefd, LLC49,0980 (0.00%)0.04%$0 MOct 23, 2026
35Morgan Stanley49,067+7,035 (+16.74%)0.04%$0 MNov 13, 2026
36Procyon Advisors, LLC47,7530 (0.00%)0.04%$0 MOct 21, 2026
37AQR Capital Management LLC44,311New0.04%$0 MNov 16, 2026
38UBS Group AG43,881+13,452 (+44.21%)0.04%$0 MNov 10, 2026
39Jpmorgan Chase & Co43,581+4,627 (+11.88%)0.04%$0 MNov 12, 2026
40Gsa Capital Partners LLP43,164New0.04%$0 MNov 16, 2026
41Essential Planning, LLC.42,3980 (0.00%)0.04%$0 MOct 21, 2026
42Global Retirement Partners, LLC40,084+31,584 (+371.58%)0.04%$0 MNov 10, 2026
43Sanctuary Advisors, LLC39,978+40 (+0.10%)0.04%$0 MNov 13, 2026
44Susquehanna International Group, LLP38,376+10,231 (+36.35%)0.03%$0 MNov 16, 2026
45MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.37,991+1,943 (+5.39%)0.03%$0 MNov 16, 2026
46Signature Estate & Investment Advisors LLC35,474New0.03%$0 MOct 13, 2026
47EP Wealth Advisors, LLC34,7250 (0.00%)0.03%$0 MNov 13, 2026
48Barclays PLC31,840+13,351 (+72.21%)0.03%$0 MNov 6, 2026
49Police & Firemen's Retirement System of New Jersey30,6840 (0.00%)0.03%$0 MNov 9, 2026
50Parallel Advisors, LLC27,3260 (0.00%)0.02%$0 MNov 3, 2026
51Wells Fargo & Company/mn26,372-47,620 (-64.36%)0.02%$0 MNov 16, 2026
52Virtu Financial LLC24,279New0.02%$0 MNov 17, 2026
53Osaic Holdings, Inc.21,227+4,245 (+25.00%)0.02%$0 MNov 12, 2026
54Vanguard Global Advisers, LLC20,883+385 (+1.88%)0.02%$0 MNov 13, 2026
55Knollwood Investment Advisory, LLC20,0000 (0.00%)0.02%$0 MNov 13, 2026
56BNP Paribas Financial Markets18,871+6,632 (+54.19%)0.02%$0 MNov 12, 2026
57Royal Bank Of Canada18,574+16,017 (+626.40%)0.02%$0 MNov 16, 2026
58New York State Common Retirement Fund17,4000 (0.00%)0.02%$0 MNov 17, 2026
59Strs Ohio15,3000 (0.00%)0.01%$0 MOct 30, 2026
60Alliancebernstein L.P.14,8000 (0.00%)0.01%$0 MNov 16, 2026
61Colton Groome Financial Advisors, LLC14,247New0.01%$0 MOct 6, 2026
62Tower Research Capital LLC (TRC)13,528+8,702 (+180.31%)0.01%$0 MNov 16, 2026
63Commonwealth Equity Services, LLC13,410+1,500 (+12.59%)0.01%$0 MNov 2, 2026
64LPL Financial LLC12,525-19,275 (-60.61%)0.01%$0 MNov 6, 2026
65Prudential Financial Inc11,2600 (0.00%)0.01%$0 MNov 16, 2026
66UNIVEST FINANCIAL Corp10,7520 (0.00%)0.01%$0 MNov 5, 2026
67Pathstone Holdings, LLC10,013New0.01%$0 MNov 13, 2026
6849 Wealth Management, LLC10,000New0.01%$0 MNov 13, 2026
69Legal & General Group Plc7,6360 (0.00%)0.01%$0 MNov 16, 2026
70Ameritas Investment Partners, Inc.7,1050 (0.00%)0.01%$0 MNov 13, 2026
71Caz Investments LP5,0000 (0.00%)0.00%$0 MNov 16, 2026
72Citigroup Inc3,883-52,514 (-93.11%)0.00%$0 MNov 4, 2026
73Simplex Trading, LLC3,079-8,597 (-73.63%)0.00%$0 MNov 4, 2026
74Birchbrook, Inc.3,0000 (0.00%)0.00%$0 MOct 14, 2026
75Sterling Capital Management LLC2,568+2,293 (+833.82%)0.00%$0 MOct 22, 2026
76GAMMA Investing LLC1,860New0.00%$0 MOct 8, 2026
77MTM Investment Management, LLC5000 (0.00%)0.00%$0 MOct 30, 2026
78Allworth Financial LP475New0.00%$0 MNov 17, 2026
79SJS Investment Consulting Inc.401New0.00%$0 MOct 26, 2026
80FMR LLC391-86 (-18.03%)0.00%$0 MNov 10, 2026
81Jones Financial Companies Lllp1090 (0.00%)0.00%$0 MNov 13, 2026
82Farther Finance Advisors, LLC91New0.00%$0 MOct 8, 2026
83Arax Advisory Partners77New0.00%$0 MNov 12, 2026
84EverSource Wealth Advisors, LLC49New0.00%$0 MNov 4, 2026
85IFP Advisors, Inc7New0.00%$0 MOct 16, 2026
86Essential Partners LLC4New0.00%$0 MOct 14, 2026
87Caitong International Asset Management Co., Ltd1New0.00%$0 MOct 29, 2026

Mutual funds holding Hyperfine, Inc.#

42 funds hold shares worth $11 M (about 8.7% of the company). Since their previous reports 37 added shares and 1 sold, buying $6 M net.
Mutual funds holding Hyperfine, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.2.34 M$3 M2.3%<0.01%+0.4%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors1.69 M$2 M1.7%<0.01%newJun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.939,686$1 M0.93%<0.01%−8.1%Jun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors735,193$1 M0.72%<0.01%newJun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC848,193$1 M0.84%<0.01%newJul 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC432,145$1 M0.43%<0.01%+4.3%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors261,866$0 M0.26%0.02%newJun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC136,110$0 M0.13%<0.01%no changeMay 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC146,339$0 M0.14%<0.01%newJun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC121,907$0 M0.12%<0.01%+12%May 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.190,235$0 M0.19%<0.01%newJul 31, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC97,800$0 M0.10%0.09%no changeJun 30, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC81,169$0 M0.08%<0.01%newJun 30, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC116,920$0 M0.12%0.01%newJul 31, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC72,580$0 M0.07%<0.01%newJun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC102,831$0 M0.10%<0.01%newJul 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC54,041$0 M0.05%<0.01%+20%May 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation60,300$0 M0.06%<0.01%newJun 30, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.49,477$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.49,514$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.40,754$0 M0.04%<0.01%newJun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC37,411$0 M0.04%<0.01%newJul 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC21,908$0 M0.02%<0.01%newJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC17,482$0 M0.02%0.01%newJun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS17,381$0 M0.02%<0.01%newJun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC17,209$0 M0.02%<0.01%newJun 30, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.12,341$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.11,801$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC11,698$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC10,350$0 M0.01%<0.01%newJun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.9,800$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC7,400$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC7,400$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC7,213$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management7,105$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC9,167$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC6,260$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.9,009$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS6,943$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC5,992$0 M<0.01%<0.01%newJul 31, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC3,713$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc.1,976$0 M<0.01%<0.01%newJun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 42 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Hyperfine, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$46 K
7 sales, 2 insiders
Net, 12 months
-$46 K
open market only
Insiders on file
15
since
-$29 K$0Nov 2023: bought $0 (0 trades), sold $3 K (1 trades)Nov 23Feb 2024: bought $0 (0 trades), sold $4 K (1 trades)May 2024: bought $0 (0 trades), sold $2 K (1 trades)MayAug 2024: bought $0 (0 trades), sold $3 K (1 trades)Nov 2024: bought $0 (0 trades), sold $2 K (1 trades)NovFeb 2025: bought $0 (0 trades), sold $4 K (1 trades)May 2025: bought $0 (0 trades), sold $2 K (1 trades)MayAug 2025: bought $0 (0 trades), sold $2 K (1 trades)Nov 2025: bought $0 (0 trades), sold $2 K (1 trades)NovFeb 2026: bought $0 (0 trades), sold $911 (1 trades)Mar 2026: bought $0 (0 trades), sold $29 K (2 trades)MarMay 2026: bought $0 (0 trades), sold $10 K (2 trades)Aug 2026: bought $0 (0 trades), sold $6 K (2 trades)Aug
Bought (open market)Sold (open market)Hover a month for the totals
Hyperfine, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Thomas TeisseyreChief Operating OfficerSell-7,345$0.850—671,256Form 4
filed Brett HaleCFO and CAOSell-7,345$0.850$6 K592,420Form 4
filed Brett HaleCFO and CAOSell-6,047$1.650—599,765Form 4
filed Thomas TeisseyreChief Operating OfficerSell-6,047$1.650$10 K678,601Form 4
filed Brett HaleCFO and CAOGrant or award+330,000——605,812Form 4
filed Maria SainzPresident and CEO, DirectorGrant or award+750,000——789,586Form 4
filed Thomas TeisseyreChief Operating OfficerGrant or award+330,000——684,648Form 4
filed Thomas TeisseyreChief Operating OfficerSell-24,188$1.210—354,648Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Hyperfine, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
3.9 M
7.97 days to cover
Shares sold short, last 24 reportsAll stocks →

Fails to deliver

  • : 30 shares at $0.73
  • : 8,696 shares at $0.85
  • : 6,129 shares at $0.87
  • : 76,594 shares at $0.89
  • : 163 shares at $0.87

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Hyperfine, Inc. scorecard#

Passes 9 of the 22 checks that could be worked out: strongest in growth (4 of 6), weakest in valuation (1 of 5). Fiscal year 2025; market cap of Oct 23, 2026.

  • Valuation1 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median1.9×Price to book 1.9× against Medical Devices's median of 2.5×.
    • ✗Price to sales below its peers' median4.1×Price to sales 4.1× against Medical Devices's median of 2.4×.
    • ✗Free cash flow yield above 5%-37.6%Free cash flow is -37.6% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth4 of 6
    • ✓Revenue grew in the newest year5.2%Revenue up 5.2% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years25.8%25.8% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median25.8%25.8% a year against Medical Devices's median of 10.8% (73 companies).
    • ✗Earnings per share grew in the newest year-0.43 vs -0.56Diluted EPS -0.43 in fiscal 2025 against -0.56 the year before (report's currency).
    • ✗Net income higher than five years earlier-$36 M-$36 M in fiscal 2025 against -$23 M in 2020.
    • ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
  • Profitability1 of 5
    • ✗Profitable in the newest year-$36 MNet income -$36 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-273.4%-273.4% against Medical Devices's median of -8.2% (86 companies).
    • ✗Return on equity above 15%-79.0%-79.0% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier-273.4%-273.4% in fiscal 2025 against -1084.7% in 2022.
  • Financial health3 of 5
    • ✓Short-term assets cover short-term liabilities4.3×Current ratio 4.34 at the end of fiscal 2025.
    • ✓Debt below equity0.0×Debt to equity 0.00 at the end of fiscal 2025.
    • ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $35 M at the end of fiscal 2025.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • ✗Altman Z-score outside the distress zone-6.22Z-score -6.22 (distress zone) for fiscal 2025.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year12.9%Diluted shares up 12.9% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Hyperfine, Inc.'s statements, beside the median of Medical Devices.

Hyperfine, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-273.5%-8.2%
Net margin-262.3%-10.4%
Return on equity-79.0%-16.8%
Revenue growth, 3 years a year25.8%10.8%
Revenue growth5.2%10.4%
Debt to equity0.00×0.64×

4of 8on the Piotroski tests of financial strength

  • Net loss of $36 million, the 6th loss-making year in a row.
  • Free cash flow was negative: -$29 million.
  • The share count rose 12.9% in the year.
  • Revenue has grown 5 years in a row.

Hyperfine, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Hyperfine, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020
Income statement
Revenue1413116.81.50.3
Cost of revenue6.87.06.35.92.70.8
Gross profit6.85.94.80.9−1.2−0.5
Research and development172222282615
Selling and marketing109.11014102.5
General and administrative16172032275.9
Operating expenses444953756423
Operating income−37−43−48−74−65−23
Interest and finance income1.02.53.80.80.00.1
Other non-operating income (expense)−0.30.00.0−0.1−0.0−0.0
Income before tax−36−41−44−73−65−23
Income tax00000—
Net income including minority interests−36−41−44−73−65−23
Net income attributable to shareholders−36−41−44−44r−65−23
Earnings per share, basic-0.43-0.56-0.62-1.04-17.57-15.38
Earnings per share, diluted-0.43-0.56-0.62-1.04-17.57-15.38
Shares, weighted average (basic)827271703.7—
Shares, weighted average (diluted)827271703.71.5
Balance sheet
Cash and cash equivalents35387511718863
Receivables5.36.03.22.10.60.2
Inventory7.15.86.64.64.31.7
Other current assets1.31.92.43.21.40.7
Current assets51548912919768
Property, plant and equipment2.53.13.03.23.81.9
Right-of-use (leased) assets0.30.30.2———
Total assets55599413420272r
Accounts payable4.11.61.20.72.20.9
Current liabilities128.78.88.8164.1r
Long-term debt0—————
Lease liabilities (non-current)0.10.10.1———
Total liabilities149.99.810164.3r
Retained earnings−330−294−254−209−136−71r
Shareholders' equity414984124186−61r
Total liabilities and equity55599413420272r
Cash-flow statement
Depreciation and amortization———1.00.70.3
Share-based compensation2.84.44.7116.91.1
Cash from operating activities−28−39−42−72−47−22
Capital expenditure−1.2−0.4−0.8−0.6−2.7−1.6
Cash from investing activities−1.2−0.4−0.8−0.6−2.7−1.6
Cash from financing activities281.00.20.017761
Report10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Hyperfine, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Device(total)$11 M84%
  • Service(total)$2 M16%

Countries and regions

  • Non-US(total)$3 M23%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Events at Hyperfine, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Delisting noticeFiling
  • Delisting noticeFiling
  • Delisting noticeFiling

Delisting notice 3 · Restructuring 1 · Directors and officers 1 · Material agreement 4 · New debt 1 · Unregistered share sale 1 · Bylaws or fiscal year changed 1 · Shareholder vote 3 · Results announced 14

Hyperfine, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Results announced8-K
Delisting notice8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Material agreementNew debtUnregistered share sale8-K
Results announced8-K
Material agreement8-K
Results announced8-K
Material agreement8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Shareholder vote8-K
Results announced8-K
Delisting notice8-K
Results announced8-K
Results announced8-K
Material agreement8-K
Restructuring8-K
Results announced8-K
Results announced8-K
Bylaws or fiscal year changedShareholder vote8-K
Delisting notice8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026

H-1B hiring at Hyperfine, Inc.#

1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $201 K a year.

Certified, FY2026
1
#1,865 among companies on value.today
Worker positions
1
Median wage offered
$201 K
a year, full-time
Applications filed
1
Hyperfine, Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Fellow, Electrical EngineerElectrical Engineers1$201 K

Where: Guilford, CT 1

Hyperfine, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202611$201 K1
FY202533$197 K3
FY202422—2
FY202322$172 K2
FY202244$173 K4

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Hyperfine, Inc.

Layoffs at Hyperfine, Inc.#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
0
2022–2025
Latest
—
2025-01-28
Hyperfine, Inc.: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2025············—
2022············—
Hyperfine, Inc.: latest layoffs
AnnouncedPeopleKindWhereSource
14% of workforceRestructuring planSEC 8-K“As a result, the Company has terminated approximately 14% of its global workforce.”Filing
13% of workforceRestructuring planSEC 8-K“As a result, the Company has terminated approximately 13% of its global workforce including, among others, the employees of its subsidiary, Liminal Sciences, Inc.”Filing

Source: State WARN notices and SEC 8-K item 2.05

How Hyperfine, Inc. compares in Medical Devices

  • Market cap$78 M · higher than 33% of 142
  • Revenue$14 M · higher than 19% of 155
  • Net margin-156.6% · higher than 10% of 144
  • Revenue growth5.2% · higher than 35% of 104
  • Price / sales4.1× · lower than 38% of 96
  • Price / book1.9× · lower than 63% of 99
  • FCF yield-37.6% · higher than 20% of 76

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
Hyperfine, Inc.🇺🇸$78 M—-156.6%+5.2%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 23, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of February 15, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Hyperfine, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Hyperfine, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Hyperfine, Inc.? Suggest a correction